
Cosmosid
CosmosID Inc: Rapid microorganism identification for diagnostics, public health, food safety, and wellness.

CosmosID Inc: Rapid microorganism identification for diagnostics, public health, food safety, and wellness.
cosmosid.comCrawled Oct 15, 2026
A shotgun metagenonimcs study powered by CosmosID illustrates associations between Gulf War illness (GWI) and gut microbiome variation.
CosmosID features informative articles, industry news, company updates, and opinions.
A new microbiome study illustrates that gut microbiome may impact voluntary human exercise behaviour and exercise capacity.
Data from healthy and end-stage renal failure patients was analyzed on CosmosID-HUB and illustrated microbiome variation.
CosmosID publishes press releases about microbiome genomics, including scientific breakthroughs and innovations.
The page lists positions in the medical and science fields, including opportunities with healthcare and environmental organizations.
CosmosID seeks a Senior Marketing Coordinator to lead marketing strategies for its microbiome sector and drive brand growth and engagement.
The page covers the CosmosID management team, its quality control processes, and its work in genomics analysis.
The page features articles and contributions by Manoj Dadlani, CEO at CosmosID.
The page features Prof. Rita Colwell, a CosmosID team member who posts in the opinions section.
The page describes what CosmosID does and how its team works together to build the scientific basis for innovations and improvements.
The page provides a way to contact CosmosID with inquiries about microbiome sequencing and analysis services.
CosmosID provides award-winning NGS Services and Bioinformatics Solutions as well as rapid identification and characterization of microorganisms.
CosmosID's privacy policies address data integrity and confidentiality in microbiome research.